230 related articles for article (PubMed ID: 32726673)
1. Preparation of the protein corona: How washing shapes the proteome and influences cellular uptake of nanocarriers.
Brückner M; Simon J; Jiang S; Landfester K; Mailänder V
Acta Biomater; 2020 Sep; 114():333-342. PubMed ID: 32726673
[TBL] [Abstract][Full Text] [Related]
2. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
3. Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions.
Kokkinopoulou M; Simon J; Landfester K; Mailänder V; Lieberwirth I
Nanoscale; 2017 Jun; 9(25):8858-8870. PubMed ID: 28632260
[TBL] [Abstract][Full Text] [Related]
4. Beyond the protein corona - lipids matter for biological response of nanocarriers.
Müller J; Prozeller D; Ghazaryan A; Kokkinopoulou M; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Apr; 71():420-431. PubMed ID: 29524674
[TBL] [Abstract][Full Text] [Related]
5. Proteomics reveals time-dependent protein corona changes in the intracellular pathway.
da Costa Marques R; Hüppe N; Speth KR; Oberländer J; Lieberwirth I; Landfester K; Mailänder V
Acta Biomater; 2023 Dec; 172():355-368. PubMed ID: 37839632
[TBL] [Abstract][Full Text] [Related]
6. Temperature, concentration, and surface modification influence the cellular uptake and the protein corona of polystyrene nanoparticles.
Oberländer J; Champanhac C; da Costa Marques R; Landfester K; Mailänder V
Acta Biomater; 2022 Aug; 148():271-278. PubMed ID: 35732233
[TBL] [Abstract][Full Text] [Related]
7. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
8. Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers.
Champanhac C; Simon J; Landfester K; Mailänder V
Biomacromolecules; 2019 Oct; 20(10):3724-3732. PubMed ID: 31449399
[TBL] [Abstract][Full Text] [Related]
9. Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake.
Schöttler S; Klein K; Landfester K; Mailänder V
Nanoscale; 2016 Mar; 8(10):5526-36. PubMed ID: 26804616
[TBL] [Abstract][Full Text] [Related]
10. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
12. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
Schöttler S; Landfester K; Mailänder V
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
[TBL] [Abstract][Full Text] [Related]
13. Phosphonylation Controls the Protein Corona of Multifunctional Polyglycerol-Modified Nanocarriers.
Danner AK; Schöttler S; Alexandrino E; Hammer S; Landfester K; Mailänder V; Morsbach S; Frey H; Wurm FR
Macromol Biosci; 2019 May; 19(5):e1800468. PubMed ID: 30913379
[TBL] [Abstract][Full Text] [Related]
14. Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles.
Partikel K; Korte R; Mulac D; Humpf HU; Langer K
Beilstein J Nanotechnol; 2019; 10():1002-1015. PubMed ID: 31165027
[No Abstract] [Full Text] [Related]
15. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome.
Pisani C; Gaillard JC; Odorico M; Nyalosaso JL; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Armengaud J; Prat O
Nanoscale; 2017 Feb; 9(5):1840-1851. PubMed ID: 27858044
[TBL] [Abstract][Full Text] [Related]
16. Protein deglycosylation can drastically affect the cellular uptake.
Ghazaryan A; Landfester K; Mailänder V
Nanoscale; 2019 Jun; 11(22):10727-10737. PubMed ID: 31120044
[TBL] [Abstract][Full Text] [Related]
17. Identification of main influencing factors on the protein corona composition of PLGA and PLA nanoparticles.
Spreen H; Behrens M; Mulac D; Humpf HU; Langer K
Eur J Pharm Biopharm; 2021 Jun; 163():212-222. PubMed ID: 33862242
[TBL] [Abstract][Full Text] [Related]
18. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Dominant IgG Adsorption on Nanocarriers in IgG-Enriched Blood Plasma by Clusterin Precoating.
Prozeller D; Pereira J; Simon J; Mailänder V; Morsbach S; Landfester K
Adv Sci (Weinh); 2019 May; 6(10):1802199. PubMed ID: 31131195
[TBL] [Abstract][Full Text] [Related]
20. Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.
Winzen S; Schoettler S; Baier G; Rosenauer C; Mailaender V; Landfester K; Mohr K
Nanoscale; 2015 Feb; 7(7):2992-3001. PubMed ID: 25599336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
